skip to main content

Opens in a new window Opens an external site Opens an external site in a new tab

When autocomplete results are available use up and down arrows to review and enter to select.

About
Team
Cases

Join us on LinkedIn

June 26, 2009

Pfizer Canada Inc. v. Apotex Inc.

Home | Cases | Pfizer Canada Inc. v. Apotex Inc.

Peter Wilcox acted for Pfizer in a proceeding related to amlodipine (NORVASC®), including successfully resisting a motion to dismiss.

pdf

Pfizer Canada Inc. v. Apotex Inc.

Related Expertise

Patent Litigation
Patent Opinion

Related cases

February 16, 2024

Janssen Inc. v Pharmascience Inc.

Counsel: Marian Wolanski, Megan Pocalyuko and Oleyna Strigul
January 12, 2024

Janssen Inc. v Apotex Inc.

Counsel: Marian Wolanski, Megan Pocalyuko and Oleyna Strigul
January 12, 2024

Janssen v. Pharmascience

Counsel: Marian Wolanski, Megan Pocalyuko and Oleyna Strigul
December 22, 2023

Janssen Inc. v Apotex Inc.

Counsel: Marian Wolanski, Megan Pocalyuko and Oleyna Strigul
March 23, 2023

Janssen Inc. et al v. Teva Canada Limited

Counsel: Marian Wolanski and Megan Pocalyuko
October 27, 2022

Janssen v. Apotex

Counsel: Stephanie Anderson

Belmore Neidrauer LLP
TD North Tower, 77 King Street West, Suite 4020
PO Box 16, TD Centre, Toronto, ON, M5K 1A1
- p.(416) 863-1771
- f.(416) 863-9171
- e.info@belmorelaw.com

About
Team
Cases
Privacy Policy

Join us on LinkedIn

© 2023 Belmore Neidrauer LLP | Legal Disclaimer

Law Firm Marketing | Cubicle Fugitive